Eric G Pamer

USPTO Granted Patents = 11 (Patent Applications = 10)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 12(Granted Patents)

Location History:

Guilford, CT (US) (2018 - 2022)
Montclair, NJ (US) (2020 - 2024)

Company Filing History:

11 out of 559

Memorial Sloan Kettering Cancer Center

Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana (fisabio)

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12414969 - Methods and compositions for reducing clostridium difficile infection (2025-09-16),

2. 12257284 - Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof (2025-03-25),

3. 11860163 - Methods and compositions for identifying and treating subjects at risk for poor CAR T cell therapy response (2024-01-02),

4. 11471495 - Methods and compositions for reducinginfection (2022-10-18),

5. 11364269 - Methods and compositions for reducinginfection or colonization (2022-06-21),

6. 11207374 - Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof (2021-12-28),

7. 11197897 - Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization (2021-12-14),

8. 11045506 - Methods and compositions for identifying and treating subjects at risk for checkpoint blockade therapy associated colitis (2021-06-29),

9. 10646520 - Methods and compositions for reducing vancomycin-resistantinfection or colonization (2020-05-12),

10. 10226443 - Methods for treating psoriatic arthritis (2019-03-12),

11. 10011883 - Causative agents and diagnostic methods relating to rheumatoid arthritis (2018-07-03),

Title: Innovations and Contributions of Eric G Pamer

Introduction

Eric G Pamer is a notable inventor based in Guilford, Connecticut, with a significant contribution to the field of microbiology and infectious diseases. He holds a total of 11 patents, showcasing his innovative approaches to combating infections, particularly those caused by gram-positive bacteria.

Latest Patents

Among his latest patents, Pamer has developed methods and compositions for reducing the risk and severity of Clostridium difficile infections. This invention is based on the discovery that a restricted fraction of the gut microbiota, including specific bacteria, plays a crucial role in enhancing resistance against such infections. It is believed that this resistance is achieved through the biosynthesis of secondary bile acids. Additionally, he has worked on novel lantibiotics and lantibiotic-producing bacteria, which are aimed at treating infections caused by gram-positive bacteria, including vancomycin-resistant enterococci. These innovations also include methods for producing and utilizing these lantibiotics to prevent contamination in food and other objects.

Career Highlights

Pamer has had a distinguished career, working with prestigious institutions such as Memorial Sloan Kettering Cancer Center and New York University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Peter McKenney and Silvia Caballero, who have collaborated with him on various projects and research initiatives.

Conclusion

Eric G Pamer's contributions to the field of microbiology and his innovative patents reflect his commitment to advancing medical science and improving public health. His work continues to influence the development of new treatments for bacterial infections.

This text is generated by artificial intelligence and may not be accurate.